BibTex format
@inproceedings{French:2019:neuonc/noz126.154,
author = {French, P and Eoli, M and Sepulveda, J and de, Heer I and Kros, JM and Walenkamp, A and Frenel, J and Franceschi, E and Clement, P and Weller, M and Ansell, P and Looman, J and Bain, E and Morfouace, M and Gorlia, T and van, den Bent M},
doi = {neuonc/noz126.154},
pages = {43--44},
publisher = {OXFORD UNIV PRESS INC},
title = {DEFINING <i>EGFR</i> AMPLIFICATION STATUS FOR CLINICAL TRIAL INCLUSION},
url = {http://dx.doi.org/10.1093/neuonc/noz126.154},
year = {2019}
}
RIS format (EndNote, RefMan)
TY - CPAPER
AU - French,P
AU - Eoli,M
AU - Sepulveda,J
AU - de,Heer I
AU - Kros,JM
AU - Walenkamp,A
AU - Frenel,J
AU - Franceschi,E
AU - Clement,P
AU - Weller,M
AU - Ansell,P
AU - Looman,J
AU - Bain,E
AU - Morfouace,M
AU - Gorlia,T
AU - van,den Bent M
DO - neuonc/noz126.154
EP - 44
PB - OXFORD UNIV PRESS INC
PY - 2019///
SN - 1522-8517
SP - 43
TI - DEFINING <i>EGFR</i> AMPLIFICATION STATUS FOR CLINICAL TRIAL INCLUSION
UR - http://dx.doi.org/10.1093/neuonc/noz126.154
ER -